Forwarded by the Los Angeles County Department of Public Health
Forwarded by the Los Angeles County Department of Public Health
CDPH Health Advisory:
California Statewide Discontinuation of Ciprofloxacin for Invasive Meningococcal Disease Post-Exposure Prophylaxis
October 11, 2024
The California Department of Public Health (CDPH) recommends that healthcare providers throughout California discontinue the use of ciprofloxacin for the post-exposure prophylaxis (PEP) of invasive meningococcal disease (IMD) due to the rise of ciprofloxacin-resistant strains of Neisseria meningitidis.
Rifampin, ceftriaxone, or azithromycin are the recommended options for IMD PEP in California. No changes to empiric treatment of IMD are currently recommended.
Earlier in 2024, the Southern California region met the threshold to discontinue ciprofloxacin IMD PEP. CDPH is now issuing this recommendation statewide.
Read the full CDPH Health Advisory
You can also copy and paste this link into your browser: 
https://www.cdph.ca.gov/Programs/OPA/Pages/CAHAN/ca-discontinuation-of-ciprofloxacin-for-invasive-meningococcal-disease-pep.aspx
To view this and other communications or to sign-up to receive LAHANs, please visit ph.lacounty.gov/lahan.
Manage your profile/DPH subscriptions
Opt out of all DPH subscriptions (LAHAN and Rx) using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
Want to view this online? View online
241 N. Figueroa St. Suite 275
Los Angeles, CA | 90012 US
This email was sent to hanhelp@ph.lacounty.gov.
To continue receiving our emails, add us to your address book.
powered by emma